189 related articles for article (PubMed ID: 26906063)
1. Rituximab in lupus nephritis: A non-systematic review.
Zurita Gavilanes L; Costa Valarezo A
Reumatol Clin; 2016; 12(4):210-5. PubMed ID: 26906063
[TBL] [Abstract][Full Text] [Related]
2. Rituximab in systemic lupus erythematosus and lupus nephritis.
Beckwith H; Lightstone L
Nephron Clin Pract; 2014; 128(3-4):250-4. PubMed ID: 25471633
[TBL] [Abstract][Full Text] [Related]
3. Rituximab treatment in lupus nephritis--where do we stand?
Gunnarsson I; Jonsdottir T
Lupus; 2013 Apr; 22(4):381-9. PubMed ID: 23553781
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy.
Tanaka Y; Takeuchi T; Miyasaka N; Sumida T; Mimori T; Koike T; Endo K; Mashino N; Yamamoto K
Mod Rheumatol; 2016; 26(1):80-6. PubMed ID: 26054418
[TBL] [Abstract][Full Text] [Related]
5. Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis.
Weidenbusch M; Römmele C; Schröttle A; Anders HJ
Nephrol Dial Transplant; 2013 Jan; 28(1):106-11. PubMed ID: 22764193
[TBL] [Abstract][Full Text] [Related]
6. Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Atisha-Fregoso Y; Malkiel S; Harris KM; Byron M; Ding L; Kanaparthi S; Barry WT; Gao W; Ryker K; Tosta P; Askanase AD; Boackle SA; Chatham WW; Kamen DL; Karp DR; Kirou KA; Sam Lim S; Marder B; McMahon M; Parikh SV; Pendergraft WF; Podoll AS; Saxena A; Wofsy D; Diamond B; Smilek DE; Aranow C; Dall'Era M
Arthritis Rheumatol; 2021 Jan; 73(1):121-131. PubMed ID: 32755035
[TBL] [Abstract][Full Text] [Related]
7. Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy.
Camous L; Melander C; Vallet M; Squalli T; Knebelmann B; Noël LH; Fakhouri F
Am J Kidney Dis; 2008 Aug; 52(2):346-52. PubMed ID: 18572292
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
[TBL] [Abstract][Full Text] [Related]
9. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
[TBL] [Abstract][Full Text] [Related]
10. [Is rituximab effective for induction of remission in lupus nephritis?].
Mac-Namara M; Rada G
Medwave; 2014 Aug; 14(7):e6010. PubMed ID: 25334007
[TBL] [Abstract][Full Text] [Related]
11. Rethinking biologics in lupus nephritis.
Venuturupalli S
Lupus; 2016 Sep; 25(10):1102-10. PubMed ID: 27497255
[TBL] [Abstract][Full Text] [Related]
12. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
Furie R; Toder K; Zapantis E
Semin Nephrol; 2015 Sep; 35(5):509-20. PubMed ID: 26573553
[TBL] [Abstract][Full Text] [Related]
13. Rituximab treatment in resistant lupus nephritis: A single-center prospective study.
Alam S; Mazumder MA; Sharma M; Mahanta PJ; Parry MA; Doley PK
Clin Nephrol; 2024 Jul; 102():1-7. PubMed ID: 38660888
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review.
Contis A; Vanquaethem H; Truchetet ME; Couzi L; Rigothier C; Richez C; Lazaro E; Duffau P
Clin Rheumatol; 2016 Feb; 35(2):517-22. PubMed ID: 26762196
[TBL] [Abstract][Full Text] [Related]
15. [An innovative approach to the treatment of immune-mediated glomerular diseases].
Roccatello D
G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832439
[TBL] [Abstract][Full Text] [Related]
16. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
17. Minimising steroids in lupus nephritis--will B cell depletion pave the way?
Lightstone L
Lupus; 2013 Apr; 22(4):390-9. PubMed ID: 23553782
[TBL] [Abstract][Full Text] [Related]
18. Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab.
Tsanyan ME; Soloviev SK; Radenska-Lopovok SG; Torgashina AV; Nikolaeva EV; Khrennikov YB; Nasonov EL
Folia Med (Plovdiv); 2014; 56(4):245-52. PubMed ID: 26444353
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.
Vigna-Perez M; Hernández-Castro B; Paredes-Saharopulos O; Portales-Pérez D; Baranda L; Abud-Mendoza C; González-Amaro R
Arthritis Res Ther; 2006; 8(3):R83. PubMed ID: 16677395
[TBL] [Abstract][Full Text] [Related]
20. Lupus nephritis: where are we now?
Lightstone L
Curr Opin Rheumatol; 2010 May; 22(3):252-6. PubMed ID: 20305561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
